Short answer
Beauty Health Co (SKIN) filed an 8-K current report with the SEC on April 22, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.2). Board expanded to 11 directors with appointments of Kenneth Tripp, Sachin Shridharani, and E. Scott Beattie effective April 17, 2026.
Beauty Health Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded to 11 directors with appointments of Kenneth Tripp, Sachin Shridharani, and E. Scott Beattie effective April 17, 2026
- New directors add medical-device operations, cosmetic medicine, and global beauty-brand expertise
- All three directors qualify as independent under Nasdaq and SEC rules, supporting governance compliance
- Ms. Gruber and Dr. Schaison will not stand for reelection, with Board expected to return to 9 directors after the 2026 annual meeting
- Committee assignments: Tripp to Audit, Shridharani to Nominating and Corporate Governance, Beattie to Compensation
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Corporate name changed to “SkinHealth Systems Inc.” effective April 22, 2026
- Name change required no stockholder vote and does not alter stockholder rights
- Bylaws now require activist nominators to represent Rule 14a-19 compliance and provide evidence five business days before meetings
- Vacancy-appointed directors serve until the next annual meeting, aligning with the declassified board structure
- Chairman duties now determined by the Board, replacing specified acquisition-oversight responsibilities
Item 7.01 · Regulation FD Disclosure
- April 22, 2026 press release announced SkinHealth Systems’ name change
- Separate April 22, 2026 release announced Tripp, Beattie, and Dr. Shridharani joining the Board
- Board expansion may signal governance or strategic repositioning for investors
- Forward-looking statements in both releases carry material execution and outcome risks
Item EX-99.1 · Exhibit EX-99.2
- Corporate rebrand effective immediately to SkinHealth Systems Inc., signaling a strategic shift toward clinically driven medical aesthetics
- Nasdaq Capital Market listing and ticker “SKIN” unchanged, limiting immediate trading disruption for shareholders
- New strategy emphasizes device utilization and consumables across an installed base exceeding 36,000 devices worldwide
- Hydrafacial remains flagship brand, complemented by SkinStylus and HydraScalp with Keravive offerings
- Execution risk includes customer reaction, litigation, regulatory changes, and ability to deliver the new operating plan
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Beauty Health Co 8-K filings
Get the next SKIN 8-K as it lands
Follow SKIN for push alerts, or ask the research agent what this filing means.